Redhill Biopharma Announced Issue Of New U.S. Patent Covering Talicia As An All-in-one Fixed-dose Combination Of Amoxicillin, Omeprazole And Rifabutin And Its Use For Helicobacter Pylori; Expected To Provide Protection For Talicia Until Feb 12, 2034
Redhill Biopharma宣布发布新的美国专利，涵盖塔利西亚作为阿莫西林、奥美拉唑和利福布汀的一体化固定剂量组合物及其用于幽门螺杆菌的用途；预计将在2034年2月12日之前为塔利西亚提供保护